JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 8 1257-1263
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bénard, F.
Right arrow Articles by Alavi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bénard, F.
Right arrow Articles by Alavi, A.

Clinical Evaluation of Processing Techniques for Attenuation Correction with 137Cs in Whole-Body PET Imaging

François Bénard, Robin J. Smith, Roland Hustinx, Joel S. Karp and Abass Alavi

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: Abass Alavi, MD, Division of Nuclear Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St., Donner Bldg. 110, Philadelphia, PA, 19130.

ABSTRACT

Transmission scanning can be successfully performed with a 137Cs single-photon emitting point source for three-dimensional PET imaging. However, the attenuation coefficients provided by this method are underestimated because of the energy difference between 662- and 511-keV photons, as well as scatter and emission contamination when the transmission data are acquired after injection. The purpose of this study was to evaluate, from a clinical perspective, the relative benefits of various processing schemes to resolve these issues. Methods: Thirty-eight whole body PET studies acquired with postinjection singles transmission scans were analyzed. The transmission images were processed and applied to the emission data for attenuation correction. Three processing techniques were compared: simple segmentation (SEG) of the transmission scan, emission contamination subtraction with scaling (ECS) of the resulting data to 511-keV attenuation coefficient values and a hybrid technique performing partial segmentation of some tissue densities on the ECS scan (THR). The corrected emission scans were blindly assessed for image noise, the presence of edge artifacts at the lung— soft-tissue interface and for overall diagnostic confidence using a semiquantitative scoring system. The count densities and the SDs in uniform structures were compared among the various techniques. The observations for each method were compared using a paired t test. Results: The SEG technique produced images that were visually less noisy than the ECS method (P < 0.0001) and the THR technique, but at the expense of increased edge artifacts at the boundaries between the lungs and surrounding tissues. The THR technique failed to eliminate these artifacts compared with the ECS technique (P < 0.0001) but preserved the activity gradients in the hilar areas. The count densities (and thus, the standardized uptake values) were similar among the three techniques, but the SEG method tended to underestimate the activity in the lung fields and in chest tumors (slope = 0.79 and 0.94, respectively). Conclusion: For many clinical applications, SEG data remain an efficient method for processing 137Cs transmission scans. The ECS method produced noisier images than the other two techniques but did not introduce artifacts at the lung boundaries. The THR technique, more versatile in complex anatomic areas, allowed good preservation of density gradients in the lungs.

Key Words: attenuation correction • segmentation • PET




This article has been cited by other articles:


Home page
JCOHome page
F. Cachin, H. M. Prince, A. Hogg, R. E. Ware, and R. J. Hicks
Powerful Prognostic Stratification By [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy
J. Clin. Oncol., July 1, 2006; 24(19): 3026 - 3031.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
D. Rischin, R. J. Hicks, R. Fisher, D. Binns, J. Corry, S. Porceddu, and L. J. Peters
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography-Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
J. Clin. Oncol., May 1, 2006; 24(13): 2098 - 2104.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. Kalff, C. Duong, E. G. Drummond, J. P. Matthews, and R. J. Hicks
Findings on 18F-FDG PET Scans After Neoadjuvant Chemoradiation Provides Prognostic Stratification in Patients with Locally Advanced Rectal Carcinoma Subsequently Treated by Radical Surgery
J. Nucl. Med., January 1, 2006; 47(1): 14 - 22.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Beckers, C. Ribbens, B. Andre, S. Marcelis, O. Kaye, L. Mathy, M.-J. Kaiser, R. Hustinx, J. Foidart, and M. G. Malaise
Assessment of Disease Activity in Rheumatoid Arthritis with 18F-FDG PET
J. Nucl. Med., June 1, 2004; 45(6): 956 - 964.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
V. Kalff, R. J. Hicks, R. E. Ware, A. Hogg, D. Binns, and A. F. McKenzie
The Clinical Impact of 18F-FDG PET in Patients with Suspected or Confirmed Recurrence of Colorectal Cancer: A Prospective Study
J. Nucl. Med., April 1, 2002; 43(4): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
A G Pitman, R J Hicks, D S Binns, R E Ware, V Kalff, A F McKenzie, D L Ball, and M P MacManus
Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
Br. J. Radiol., February 1, 2002; 75(890): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Hicks, V. Kalff, M. P. MacManus, R. E. Ware, A. Hogg, A. F. McKenzie, J. P. Matthews, and D. L. Ball
18F-FDG PET Provides High-Impact and Powerful Prognostic Stratification in Staging Newly Diagnosed Non-Small Cell Lung Cancer
J. Nucl. Med., November 1, 2001; 42(11): 1596 - 1604.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Hicks, V. Kalff, M. P. MacManus, R. E. Ware, A. F. McKenzie, J. P. Matthews, and D. L. Ball
The Utility of 18F-FDG PET for Suspected Recurrent Non-Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
J. Nucl. Med., November 1, 2001; 42(11): 1605 - 1613.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Hicks, D. Binns, and M. G. Stabin
Pattern of Uptake and Excretion of 18F-FDG in the Lactating Breast
J. Nucl. Med., August 1, 2001; 42(8): 1238 - 1242.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.